Oct 16, 2017 11:30 am UTC| Business
SAN DIEGO, CA, Oct. 16, 2017 -- Global Payout, Inc. (OTCPink: GOHE) (“Global”) is pleased to announce that its majority owned subsidiary, MoneyTrac Technology, Inc. (“MTRAC”, the “Company”), in addition to its newly...
TG Therapeutics Announces Completion of Full Enrollment in the UNITY-CLL Phase 3 Trial
Oct 16, 2017 11:30 am UTC| Business
Top-Line ORR data from the UNITY-CLL trial expected in 2Q18 Targeting an NDA/BLA filing for combination of TGR-1202 + TG-1101 in 2H18 NEW YORK, Oct. 16, 2017 -- TG Therapeutics (NASDAQ:TGTX) announced today that it...
TG Therapeutics Provides Update on FDA Meeting for GENUINE Phase 3 Trial
Oct 16, 2017 11:30 am UTC| Business
NEW YORK, Oct. 16, 2017 -- TG Therapeutics (NASDAQ:TGTX) announced today that it has met with the U.S. Food and Drug Administration (FDA) regarding the use of the results from the GENUINE Phase 3 trial to support a...
McDermott Announces Date for Third Quarter 2017 Financial Results and Conference Call
Oct 16, 2017 11:30 am UTC| Business
HOUSTON, Oct. 16, 2017 -- McDermott International, Inc. (NYSE:MDR) will report financial results for the third quarter of 2017 on Wednesday, November 1, 2017. President and Chief Executive Officer David Dickson and...
Oct 16, 2017 11:30 am UTC| Business
MENLO PARK, Calif., Oct. 16, 2017 -- A series of publications and initiatives from the genomics community demonstrates the rapid adoption of Single Molecule, Real-Time (SMRT®) Sequencing for discovering structural...
Oct 16, 2017 11:30 am UTC| Business
SAN DIEGO, Oct. 16, 2017 -- Kura Oncology, Inc. (Nasdaq:KURA), a clinical stage biopharmaceutical company focused on the development of precision medicines for oncology, today announced presentations at the...
Actinium Pharmaceuticals to Present at BIO Investor Forum
Oct 16, 2017 11:30 am UTC| Business
- Actinium to present on Tuesday, October 17th at 3 PM PT NEW YORK, Oct. 16, 2017 -- Actinium Pharmaceuticals, Inc. (NYSE American:ATNM) ("Actinium" or "the Company"), a biopharmaceutical company developing innovative...